The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ajp.123.8.947

Previous studies from the Lafayette Clinic have reported a protein factor, identified by the L/P ratio, found in significantly greater concentration in the plasma of chronic schizophrenic patients than in that of some control subjects. Other schizophrenic patients clinically very similar do not have the factor. Family members of high-factor patients were more likely to have elevated L/P ratios than were family members of low-factor patients. In this study, 117 family members of the patients were seen for psychiatric evaluation and psychological testing. In these family members schizophrenic symptomatology was not found to correlate with elevation of the L/P ratio. The authors conclude that the protein factor is not directly related to clinical manifestations of schizophrenia.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.